معرفی
Zhang Lixin is a Professor and Foreign Member of the European Academy of Sciences at East China University of Science and Technology. He serves as Director of the National Key Laboratory of Bioreactor Engineering and holds leadership roles in multiple research programs. His academic journey includes a PhD from the Chinese Academy of Sciences and postdoctoral work at Emory University.
- Education: PhD in Microbial Pharmacy (1994), Master in Microbial Pharmacy (1990), Bachelor in Microbiology (1990)
- Current Affiliation: School of Bioengineering, East China University of Science and Technology
His research integrates synthetic biology with bioreactor engineering to address key challenges in intelligent biomanufacturing, including cellular metabolic conversion mechanisms and large-scale production bottlenecks. His work spans microbial drug discovery, green manufacturing of high-value compounds like coenzyme Q10 and astaxanthin, and CRISPR-based biosensing platforms.
Recent publications highlight advancements in porphyrin production (2024), CRISPR-Cas systems (2023), and metabolic engineering of Streptomyces for polyketides (2020). His research trends emphasize synthetic regulatory elements, thermostable genetic tools, and high-throughput screening methodologies.
Major scientific awards include:
- National Science and Technology Progress Award (2016, Second Prize)
- WuXi AppTec Life Chemistry Research Award (2017)
- Inner Mongolia Science and Technology Progress Award (2011, First Prize)
- Royal Society-Roche Young Scientist Award (2014)
- UNIDO Global Science and Technology Innovation Silver Medal (2022)
Zhang has secured major grants including National Key R&D Program (Synthetic Biology), National Natural Science Foundation projects, and EU PharmaSea program. He founded the journal Synthetic and Systems Biotechnology and received the Outstanding Editor-in-Chief Award (2023).
